BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 9782754)

  • 1. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined administration of long-acting antirheumatic drugs in the treatment of chronic polyarthritis].
    Wollenhaupt J; Zeidler H
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1219-23. PubMed ID: 9378046
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM; Singh G
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of slow-acting anti-rheumatic drugs (SAARDs) and combinations of SAARDs on monokine production in vitro.
    Danis VA; Franic GM; Brooks PM
    Drugs Exp Clin Res; 1991; 17(12):549-54. PubMed ID: 1841047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapy of disease-modifying antirheumatic drugs(DMARDs) in rheumatoid arthritis].
    Kobayashi S; Kanai Y
    Nihon Rinsho; 2002 Dec; 60(12):2351-6. PubMed ID: 12510361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE; Bochkova AG; Bunchuk NV
    Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy in rheumatoid arthritis].
    Johnsen V; Førre Ø; Haga HJ; Kvien TK; Mikkelsen K; Nordvåg BY; Rødevand E
    Tidsskr Nor Laegeforen; 2003 May; 123(11):1511-3. PubMed ID: 12822010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing patterns in the use of slow acting antirheumatic drugs for the treatment of rheumatoid arthritis.
    Horsfall MW; Shaw JP; Highton J; Cranch PJ
    N Z Med J; 1998 Jun; 111(1067):200-3. PubMed ID: 9673632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy.
    Fries JF; Williams CA; Singh G; Ramey DR
    J Rheumatol; 1997 May; 24(5):838-44. PubMed ID: 9150069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination drug therapy of seropositive rheumatoid arthritis.
    McCarty DJ; Harman JG; Grassanovich JL; Qian C; Klein JP
    J Rheumatol; 1995 Sep; 22(9):1636-45. PubMed ID: 8523336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-modifying agents and experimental treatments of rheumatoid arthritis.
    Weinblatt ME; Maier AL
    Clin Orthop Relat Res; 1991 Apr; (265):103-15. PubMed ID: 2009648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis--the French experience.
    Kahan A; Menkès CJ
    Lupus; 1996 Jun; 5 Suppl 1():S45-9. PubMed ID: 8803911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Armentarium and strategies for the treatment of rheumatoid arthritis].
    Lioté F
    Rev Prat; 2005 Dec; 55(19):2146-60. PubMed ID: 16544925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH; Whelton A
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When to begin rheumatism treatment? Initial combination therapy helps fastest].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):5-6. PubMed ID: 15887691
    [No Abstract]   [Full Text] [Related]  

  • 20. History of combination therapy of rheumatoid arthritis.
    Paulus HE
    J Rheumatol Suppl; 1996 Mar; 44():38-42. PubMed ID: 8833050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.